Projects funded by the NCN
The Development of a Targeted MRI Contrast Agent for Early Diagnosis of Prostate Cancer.
2018/30/M/NZ5/00844
Keywords:
Targeted Contrast Agent Molecular Magnetic Resonance Imaging Proste Cancer Core/Shell Nanoaparticles Antibodies
Descriptors:
- ST5_10: Functional materials/nanomaterials, nanoparticles
- NZ5_5: Diagnostics in human diseases
- NZ1_2: Biochemistry
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: HARMONIA 10 - announced on 2018-06-15
Amount awarded: 1 256 780 PLN
Project start date (Y-m-d): 2019-04-12
Project end date (Y-m-d): 2025-04-11
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.